Initiation of immunotherapy with activated natural killer cells and anti-GD2 antibody dinutuximab prior to resection of primary neuroblastoma prolongs survival in mice

by Jianping Sun, Larry Wang, Michael John Zobel, Abigail K Zamora, Hong-wei Wu, Danny Lascano, Jemily Malvar, Michael A Sheard, Robert C Seeger, Eugene S Kim
Published 2020-07-01